抗生素市場：依藥物類型、頻譜、給藥途徑、藥物來源、地區

Antibiotics Market, By Drug Type, By Spectrum, By Route of Administration, By Drug Origin, By Geography

出版日期: 2024年05月31日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球抗生素市場規模為553.3億美元，2031年將達782.4億美元，2024年至2031年複合年成長率為5.1%。

圖 1. 2024 年按地區分類的抗生素市場佔有率(%)

全球抗生素市場在過去幾十年中經歷了穩定成長。感染疾病的流行以及抗生素抗藥性細菌的增加，顯著增加了對更新、更有效的抗生素藥物的需求。此外，新興市場醫療保健支出的增加以及支持抗生素開拓的有利法規環境也進一步支持了市場成長。然而，開發新抗生素的成本高昂以及缺乏創新管道是限制市場擴張的主要挑戰。總體而言，由於抗藥性感染疾病治療的持續研究和開發，預計全球抗生素市場在未來幾年將出現強勁成長。

市場動態：

全球抗生素市場是由全球感染疾病發病率上升和抗生素抗藥性細菌增加所推動的。據世界衛生組織（WHO）稱，抗菌素抗藥性是全球健康面臨的最大威脅之一，並對經濟和發展構成嚴重威脅。抗生素抗藥性的增加使得許多舊抗生素對新的致病菌株無效，因此需要新的治療方法。這為藥品製造商開發創新藥物創造了重要機會。然而，開發新藥所涉及的高成本和嚴格的監管程序是主要挑戰。此外，缺乏新型抗生素管道以及對特種藥物而非感染疾病的關注威脅著永續成長。然而，透過官民合作關係支持抗生素研究和開發的舉措可以幫助克服這些障礙。

本研究的主要特點

本報告對全球抗生素市場進行了詳細分析，並介紹了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
基於公司亮點、產品系列、主要亮點、財務表現和策略等參數的全球抗生素市場主要企業的概況。
主要企業包括雅培、賽諾菲、諾華、拜耳、葛蘭素史克、阿斯特捷利康、Noreva Biotech、Emcure Pharmaceuticals、Torrent Pharma、Sun Pharmaceutical Industries Ltd.、Mylan NV、F. Hoffmann-La Roche Ltd. 和Merck & Co。
從這份報告中獲得的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球抗生素市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球抗生素市場時使用的各種策略矩陣來促進決策。

The global antibiotics market has been witnessing steady growth over the past few decades. Rising prevalence of infectious diseases along with growing antibiotic resistance has considerably fueled the demand for newer and more effective antibiotic drugs. Moreover, increasing healthcare expenditure in developing nations and favorable regulatory environment supporting antibiotic development has further propelled the market growth. However, high development cost of novel antibiotics and lack of innovative pipeline are some of the major challenges restraining market expansion. Overall, the global antibiotics market is expected to witness robust growth in the coming years driven by ongoing R&D for the treatment of drug-resistant infections.

Market Dynamics:

The global antibiotics market is driven by the rising incidence of infectious diseases worldwide and growing antibiotic resistance. According to the World Health Organization, antimicrobial resistance is one of the biggest threats to global health posing a serious economic and development threat. Growing antibiotic resistance has rendered many older antibiotics ineffective against newer pathogenic strains requiring novel treatment options. This is creating significant opportunities for drug makers to develop innovative drugs. However, high costs involved in new drug development and stringent regulatory procedures are major challenges. Moreover, lack of novel antibiotic pipeline and focus on specialty medicines over infectious diseases threatens sustainable growth. However, initiatives supporting antibiotic R&D through public-private partnerships can help overcome these barriers.

Key Features of the Study:

This report provides an in-depth analysis of the global antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Abbott , Sanofi, Novartis AG, Bayer AG, GSK plc, AstraZeneca, Noreva Biotech, Emcure Pharmaceuticals, Torrent Pharma, Sun Pharmaceutical Industries Ltd., Mylan N.V., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Otsuka Pharmaceutical Co., Ltd., and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global antibiotics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibiotics market.

Detailed Segmentation-

By Drug Type:
- Cephalosporins
- Penicillins
- Fluroquinilones
- Macrolides
- Carbapenems
- Sulfonamides
- Aminoglycosides
- Others
By Spectrum:
- Broad-Spectrum Antibiotics
- Narrow-Spectrum Antibiotics
By Route of Administration:
- Oral
- Intravenous
- Others
By Drug Origin:
- Natural
- Semisynthetic
- Artificial
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abbott
- Sanofi
- Novartis AG
- Bayer AG
- GSK plc
- AstraZeneca
- Noreva Biotech
- Emcure Pharmaceuticals
- Torrent Pharma
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Spectrum
- Market Snapshot, By Route of Administration
- Market Snapshot, By Drug Origin
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Antibiotics Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cephalosporins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Penicillins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Fluroquinilones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Macrolides
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Carbapenems
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sulfonamides
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Aminoglycosides
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Antibiotics Market, By Spectrum, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Broad-Spectrum Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Narrow-Spectrum Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Antibiotics Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Antibiotics Market, By Drug Origin, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Natural
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Semisynthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Artificial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Antibiotics Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Abbott
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
- Novartis AG
- Bayer AG
- GSK plc
- AstraZeneca
- Noreva Biotech
- Emcure Pharmaceuticals
- Torrent Pharma
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.